Skip to content

Flour particle size of breads and blood glucose and insulin response

The effect of wheat flour particle size and fibre from wheat on postprandial glycaemia among obese adults aged 55 – 75 not meeting physical activity guidelines: a randomised, controlled, cross-over study.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001142123
Enrollment
23
Registered
2019-08-16
Start date
2019-09-11
Completion date
2019-11-18
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Eating wholegrain foods can reduce the risk of developing diseases such as type 2 diabetes and cardiovascular disease. However, the range of wholegrain foods that are commercially available are made with a variety of processing methods – ranging from minimally processed, primarily intact grains, to the finely milled flour which is commonly used in commercial breads. Some evidence suggests that the extent of the grain processing may affect humans’ physiological responses to their consumption, but this is not yet fully understood. Our study aims to investigate the effect of wheat flour particle size and grain structure in breads on acute metabolic response in adults who have risk factors for developing type 2 diabetes. We will test participants’ blood glucose and insulin responses to each of the test breads over 3 hours. These results will help to identify whether a specific processing method for breads may help to reduce the risk of developing type 2 diabetes. We hypothesise that a coarser flour particle size in bread and more intact structure of the grain will result in a significantly different postprandial blood glucose response than a finer flour particle size, among adults at risk of developing metabolic disease.

Interventions

This study is a randomised crossover design to measure the blood glucose and insulin responses to breads made with different grain particle size and fibre content. It will be conducted in a research clinic at the University of Otago. The study includes three bread exposures: (1) A bread made with finely milled wholegrain flour providing 50 g available carbohydrate (approximately four to five slices), served with 250 mL water (2) A bread made with coarse stoneground wholegrain flour providing 5

This study is a randomised crossover design to measure the blood glucose and insulin responses to breads made with different grain particle size and fibre content. It will be conducted in a research clinic at the University of Otago. The study includes three bread exposures: (1) A bread made with finely milled wholegrain flour providing 50 g available carbohydrate (approximately four to five slices), served with 250 mL water (2) A bread made with coarse stoneground wholegrain flour providing 50 g available carbohydrate (approximately four to five slices), served with 250 mL water (3) A bread made with fine stoneground wholegrain flour providing 50 g available carbohydrate (approximately four to five slices), served with 250 mL water Each bread is matched for all macronutrients. They differ in the particle size and the structure of the grain. Each bread will provide 50 g available carbohydrate. Intervention order will be randomised for the four breads. Participants will be able to select the days they wish to attend the clinic for. All treatments will be administered within a 6 week period, with a minimum washout of one day between each treatment. Key measures: (1) Blood glucose will be measured via capillary blood taken from a finger prick. (2) Insulin will be measured via venous blood taken from a cannula placed into a vein in the forearm Participants will arrive at the research clinic between 7:00 AM and 7:30 AM, having completed a water-only fast for a minimum of 10 hours. A text reminder will be sent to participants 24 hours before, to remind them to adhere to fasting conditions, and to keep their exercise and evening meal consistent before testing mornings. Participants will have been provided with a food and exercise diary to complete for the 24 hours prior to testing. Upon arrival, participants will be fitted with a cannula into a vein in the forearm. This will be performed by a trained health professional (nurse or doctor). They will be given a brief questionnaire to fill out which checks adherence to the study conditions. They will be required to be seated for a minimum of 10 minutes prior to their first (baseline) blood measurements being taken. Two capillary blood samples will be taken (via fingerprick) to assess baseline (fasted) blood glucose, and a 2 mL venous blood sample will be drawn from the cannula to measure insulin at baseline. Participants will be instructed to consume their test food within 10 minutes, alongside 250 mL water. At 15 minutes following the commencement of eating, a fingerprick blood sample will be taken to measure blood glucose, and a 2 mL sample of venous blood will be drawn from the cannula to measure insulin. These blood samples will be repeated at 30, 45, 60, 90, 120, 150, and 180 minutes. At the end of the 3 hour testing session, participants will be offered a small snack to take away with them. Each morning of testing will take approximately 3.5 hours of participants' time. The total amount of blood collected each day will be 16 mL. During the 3-hour testing time, participants will remain seated, except for a bathroom break which will be scheduled at 2 hours post-meal. Participants will be free to take additional bathroom breaks if they require. The research will be delivered by Evelyn Mete (PhD Student and New Zealand Registered Dietitian), alongside a supervisory team who have many years' experience delivering similar trials.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Adults who are aged 55 - 75 years, who have a BMI equal to or greater than 30 kg/m2, and who perform less than 150 minutes of moderate to vigorous exercise per week.

Exclusion criteria

Exclusion criteria include previous diagnosis of diabetes, HbA1c measurement at or over 50 mmol/mol, current infection, taking medication known to affect or control blood glucose, weight change greater than 2% in the previous 3 months, blood donation within previous 12 weeks, avoidance of or allergy to wheat or gluten, and unwillingness/inability to comply with intervention requirements.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026